Company intelligence / Profile preview

Shenzhen Institute of Advanced Biomedical Robot

Shenzhen, Guangdong Province, Chinaipqwery.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company has developed proprietary vascular interventional surgical robots and control systems with over 470 intellectual property filings by April 2024. Several original technologies are described as reaching international leading levels. Clinical collaborations with top Chinese expert teams have been established. No published clinical trial results typical for pharmaceuticals; device performance and safety are validated through partnerships and regulatory processes.

Therapeutic areas: Cardiovascular
Modalities: DeviceRobotic-assisted surgery system
Industry: Surgical Medical Devices

Partnerships

Collaborations with leading Chinese clinical expert teams in the field of vascular intervention

Beyond the preview

Go deeper on Shenzhen Institute of Advanced Biomedical Robot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Institute of Advanced Biomedical Robot.

Explore the full profile